Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44.
about
Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakiaE-cadherin-catenin cell-cell adhesion complex and human cancerInvestigation of the effects of heparin and low molecular weight heparin on E-cadherin and laminin expression in rat pregnancy by immunohistochemistryMammary tumor induction and premature ovarian failure in ApcMin mice are not enhanced by Brca2 deficiency.Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast.Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration.CDH1 polymorphisms and haplotypes in sporadic diffuse and intestinal gastric cancer: a case-control study based on direct sequencing analysisGenetic changes of Wnt pathway genes are common events in metaplastic carcinomas of the breast.The Prognostic Value of E-cadherin Expression in Breast CancerProfiling of normal and malignant breast tissue show CD44high/CD24low phenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers.Lymph node status as a guide to selection of available prognostic markers in breast cancer: the clinical practice of the future?Observer accuracy in estimating proportions in images: implications for the semiquantitative assessment of staining reactions and a proposal for a new systemEndocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.Prognostic value of reduced E-cadherin expression in breast cancer: a meta-analysis.Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA PathwaysPrognostic significance of dysadherin expression in advanced colorectal carcinomaExpression of nm23 in the spectrum of pre-invasive, invasive and metastatic breast lesions.Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers.Canine Mammary Cancer Stem Cells are Radio- and Chemo- Resistant and Exhibit an Epithelial-Mesenchymal Transition Phenotype.Expression of matrix metalloproteinase 2 (MMP-2), E-cadherin and Ki-67 in metastatic and non-metastatic canine mammary carcinomasHedgehog signalling in breast cancer.Sclerostin is expressed in osteoclasts from aged mice and reduces osteoclast-mediated stimulation of mineralization.Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutation.Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin.Different patterns of beta-catenin expression in gastric carcinomas: relationship with clinicopathological parameters and prognostic outcome.Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.E-cadherin negatively regulates CD44-hyaluronan interaction and CD44-mediated tumor invasion and branching morphogenesis.E-cadherin and catenin expression in normal and neoplastic endocervical glandular epithelium.Co-activation of Hedgehog and Wnt signaling pathways is associated with poor outcomes in triple negative breast cancer.Immunohistochemical expression of the beta-catenin-interacting protein B9L is associated with histological high nuclear grade and immunohistochemical ErbB2/HER-2 expression in breast cancers.Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis.The expression of β-catenin in different subtypes of breast cancer and its clinical significance.Predicting invasive phenotype with CDH1, CDH13, CD44, and TIMP3 gene expression in primary breast cancer.
P2860
Q21245728-16982BEB-DFBF-4885-B2D1-50D5A3A312BBQ28142886-E8EEA9C5-C334-4B3F-A924-58342A0EF2E7Q28564234-6785A8FF-7C82-448B-95BB-A430DFC05C74Q32052529-0D5447ED-C524-4F82-BDF0-4CCB119848F1Q33918477-96CD9C45-65C5-4F70-AE48-1BABCA9F55F1Q34048070-0F259367-C2C1-408C-945B-6A5CA3C212E6Q34504297-83B9AE1E-DB52-4CF8-8314-9A2D57035F23Q34698214-A64F0214-0EB6-4E15-9BA8-A3D437E9B1E3Q34746931-5899A60B-704B-407A-BA96-63A779540C3AQ34773671-B259AA3E-8F58-4B95-9FF5-E3AB2A4CC6CBQ35157568-26D1CF29-FDC8-4A73-8E5C-B576FCCEB032Q35398756-C5C6133E-1E48-49F5-8532-2CCD3878CBA9Q35775363-D40CCDB4-7E99-4B11-93F1-4ED0F06CE39DQ36140785-F40FDF4D-B16A-4C47-B143-ED0CA8B29A75Q36266501-4CF1F6D4-F55A-4A86-96D3-3EA045EE5EA0Q36593417-3859E10B-868F-4B80-B763-0EDC5F68B19FQ36646615-86E55645-5CEE-4DA5-945C-CF79FB63091DQ36711486-5B323971-E16D-4619-AE7F-A66C00A62488Q36937053-BE73FEDD-6CE0-4EC6-95DD-13F330B0C660Q37132662-647E135C-4CEC-42CF-9EDD-9D653C6D7CFDQ37145151-8C798270-F791-49D1-904D-7ADED48AC1A2Q37214195-4A342946-7995-4BF5-B49F-09A22EF7367AQ37492408-C56F09FD-C186-4473-B7E0-71F2CF0B5ACDQ40627879-6B6BC9E1-31E0-4460-A4BA-B586C1228FEEQ42479900-DBFAED67-EA41-4459-A685-9C4F8C92B020Q42486918-BF525D15-A8D1-407B-9434-5E774B869BB7Q43700085-17118E8C-3ADC-43BD-9430-403ADCCF3CEEQ43808206-023A1A47-3519-4493-B6DD-69B1AD01CAB9Q44269066-DA95B17B-26F8-4EBD-A29B-BFE598759741Q44997090-BD2F8055-AD09-4427-B740-E4D32828DB78Q45786900-5C77119A-211C-4528-99AC-AC36932C0475Q53336607-69159646-160B-4F25-8165-6A0525285B5DQ53580829-9E98C0B1-5E88-402E-BE1E-F580D803FEAAQ54354737-5EF85C90-1EE2-4F6D-B261-8480A32648E3Q54462431-21E7B92E-2510-4859-BF2D-82FF5AC5D2E2
P2860
Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Immunophenotypic and prognosti ...... a comparative study with CD44.
@en
Immunophenotypic and prognosti ...... a comparative study with CD44.
@nl
type
label
Immunophenotypic and prognosti ...... a comparative study with CD44.
@en
Immunophenotypic and prognosti ...... a comparative study with CD44.
@nl
prefLabel
Immunophenotypic and prognosti ...... a comparative study with CD44.
@en
Immunophenotypic and prognosti ...... a comparative study with CD44.
@nl
P2093
P2860
P1433
P1476
Immunophenotypic and prognosti ...... a comparative study with CD44.
@en
P2093
Breukelmann D
Bànkfalvi A
Pschadka G
P2860
P356
10.1046/J.1365-2559.1999.00540.X
P577
1999-01-01T00:00:00Z